ORMP   $2.33  3.10% Market Closed After Close 2.2 -5.58%

Oramed Pharmaceuticals Inc

EMA (20): 2024-11-08 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2024-11-08 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.

EMA (100): 2024-10-17 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

Trend Type turning down
Power slow
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -0.43%
EMA (20) date of signal Nov. 8, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -0.43%
EMA (50) date of signal Nov. 8, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -3.97%
EMA (100) date of signal Oct. 17, 2024, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Nov. 21, 2024, 3 a.m.
MACD Signals bearish weakening
MACD Yield 0.0
MACD date of signal Nov. 21, 2024, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 0.0
Stochastic date of signal Nov. 21, 2024, 3 a.m.
Updated Nov. 21, 2024, 11:03 p.m.